Vivani Medical (NASDAQ:VANI) Director Gregg Williams Buys 1,575,231 Shares

Vivani Medical, Inc. (NASDAQ:VANI) Director Gregg Williams acquired 1,575,231 shares of the stock in a transaction dated Sunday, March 15th. The shares were bought at an average price of $1.07 per share, for a total transaction of $1,685,497.17. Following the transaction, the director owned 31,357,183 shares in the company, valued at approximately $33,552,185.81. This represents a 5.29% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Gregg Williams also recently made the following trade(s):

• On Tuesday, January 27th, Gregg Williams acquired 1,351,351 shares of Vivani Medical stock. The shares were bought at an average cost of $1.48 per share, with a total value of $1,999,999.48.
• On Thursday, January 15th, Gregg Williams bought 1,737,765 shares of Vivani Medical stock. The stock was bought at an average price of $1.14 per share, with a total value of $1,981,052.10.

Vivani Medical Stock Up 10.9%

VANI opened at $1.22 on Tuesday. The business’s fifty day simple moving average is $1.28 and its 200 day simple moving average is $1.36. Vivani Medical, Inc. has a 52 week low of $0.91 and a 52 week high of $1.92. The stock has a market cap of $95.37 million, a PE ratio of -2.71 and a beta of 3.17.

Institutional Trading of Vivani Medical

Several institutional investors have recently added to or reduced their stakes in the business. Tudor Investment Corp ET AL bought a new position in shares of Vivani Medical during the fourth quarter valued at about $1,127,000. Marshall Wace LLP bought a new stake in shares of Vivani Medical in the 4th quarter valued at about $174,000. State Street Corp boosted its holdings in Vivani Medical by 12.5% during the 4th quarter. State Street Corp now owns 144,865 shares of the company’s stock valued at $178,000 after acquiring an additional 16,070 shares during the period. Jane Street Group LLC purchased a new stake in Vivani Medical during the 4th quarter valued at about $60,000. Finally, Renaissance Technologies LLC grew its position in Vivani Medical by 118.4% during the 4th quarter. Renaissance Technologies LLC now owns 97,985 shares of the company’s stock worth $121,000 after acquiring an additional 53,127 shares during the last quarter. 6.78% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on VANI shares. Weiss Ratings reissued a “sell (d-)” rating on shares of Vivani Medical in a report on Friday, January 9th. Wall Street Zen raised Vivani Medical to a “sell” rating in a research note on Saturday, November 22nd. One research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $4.00.

About Vivani Medical

Vivani Medical Solutions, Inc (NASDAQ: VANI) is a medical technology company focused on the design, development and commercialization of advanced specimen retrieval and hemostasis products for minimally invasive diagnostic procedures. Its core mission is to enhance procedural safety and streamline clinical workflows for interventional radiologists and pathology laboratories.

The company’s flagship offerings include the StopBleed Retrieval Device and StopBleed Pad, which integrate proprietary hemostatic materials to control bleeding at biopsy sites and preserve tissue integrity.